Researchers have investigated Manfredokimab AK120, a recently developed interleukin 17A (IL-17A) antagonist, regarding treatment option for patients with ulcerative colitis. Preliminary data suggest that this therapy may present a meaningful improvement in intestinal inflammation compared to current therapies, particularly for patients who have … Read More

Andecaliximab, also known as GS-5745, represents a valuable investigative instrument within the field of immunological studies . This humanized monoclonal protein selectively interacts with CD40 ligand (CD40L), a crucial substance involved in inflammatory responses. By preventing CD40L engagement with its receiver , andecaliximab delivers resear… Read More